uk 68798 has been researched along with Recrudescence in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Baranowski, B; Bhargava, M; Callahan, TD; Cantillon, DJ; Chung, MK; Dresing, TJ; Hussein, AA; Kanj, M; Koene, RJ; Lindsay, BD; Martin, DO; Menon, V; Niebauer, MJ; Rickard, JW; Saliba, WI; Tarakji, KG; Tchou, PJ; Varma, N; Wazni, OM; Wilkoff, BL | 1 |
| Adelstein, E; Barrington, W; Bazaz, R; Brumberg, G; Gera, N; Jain, SK; Mendenhall, GS; Nemec, J; Pray, C; Saba, S; Schwartzman, D; Voigt, A; Wang, NC | 1 |
| Bilchick, KC; DiMarco, JP; Malhotra, R | 1 |
| Akerman, S; Dixit, S; Epstein, AE; Frankel, DS; Khurshid, S; Man, JP; Marchlinski, FE; Supple, G | 1 |
| Adelstein, E; Alam, MB; Jain, SK; Khattak, F; Leef, G; Munir, MB; Patel, D; Qin, D; Rattan, R; Saba, S | 1 |
| Huang, HD; Steinhaus, DA; Waks, JW; Zimetbaum, P | 1 |
| Banchs, JE; Baquero, GA; Depalma, S; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, ED; Samii, SM; Wolbrette, DL; Young, SK | 1 |
| Coleman, CI; Guertin, D; Henyan, NN; Kluger, J; McBride, BF; Min, B; Silver, BB; White, CM | 1 |
| Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T | 1 |
| DeCara, JM; Dubrey, S; Falk, RH; Pollak, A | 1 |
| Crijns, HJ; Van Gelder, IC; Van Noord, T | 1 |
3 trial(s) available for uk 68798 and Recrudescence
| Article | Year |
|---|---|
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Humans; Lactic Acid; Magnesium Compounds; Male; Phenethylamines; Recurrence; Sotalol; Statistics, Nonparametric; Sulfonamides; Treatment Outcome | 2006 |
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment | 2007 |
Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Flow Velocity; Double-Blind Method; Echocardiography, Doppler, Color; Electric Countershock; Heart Rate; Humans; Myocardial Contraction; Phenethylamines; Potassium Channel Blockers; Recurrence; Stroke Volume; Sulfonamides | 2000 |
8 other study(ies) available for uk 68798 and Recrudescence
| Article | Year |
|---|---|
Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Databases, Factual; Defibrillators, Implantable; Electric Countershock; Female; Heart Rate; Humans; Male; Middle Aged; Phenethylamines; Recovery of Function; Recurrence; Retrospective Studies; Stroke Volume; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Frequency of toxicity with chemical conversion of atrial fibrillation with dofetilide.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Chi-Square Distribution; Electric Countershock; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Recurrence; Retrospective Studies; Sulfonamides; Torsades de Pointes | 2013 |
Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Phenethylamines; Recurrence; Retrospective Studies; Sulfonamides; Treatment Outcome | 2014 |
Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Cohort Studies; Disease-Free Survival; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Phenethylamines; Predictive Value of Tests; Proportional Hazards Models; Pulse Therapy, Drug; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Time Factors; Treatment Outcome | 2015 |
Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Dronedarone; Female; Humans; Male; Patient Admission; Pennsylvania; Phenethylamines; Recurrence; Retrospective Studies; Sotalol; Stroke; Sulfonamides | 2016 |
Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Electric Countershock; Electrocardiography; Female; Heart Conduction System; Humans; Male; Massachusetts; Middle Aged; Phenethylamines; Recurrence; Retrospective Studies; Sulfonamides | 2016 |
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dose-Response Relationship, Drug; Electric Countershock; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Phenethylamines; Recurrence; Stroke Volume; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation; Ventricular Function, Left | 2012 |
Pericardioversion dofetilide does not suppress immediate and subacute recurrences of persistent atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Phenethylamines; Recurrence; Sulfonamides; Treatment Outcome | 2001 |